Vocalization for the Second Stage of Labor (VOCAL) (VOCAL)

October 3, 2019 updated by: Leila Katz, Instituto Materno Infantil Prof. Fernando Figueira

VocalizationTechnique During the Second Period of Labor Versus Usual Care for Prevention of Perineal Trauma: Randomized Clinical Trial

A randomized open-label trial will be conducted to evaluate the effect of vocalization as a perineal protection maneuver during the second period of labor. The study will be carried out in the "Espaço Aconchego" sector of the IMIP, which has a team of obstetrical nurses, medical coordination and physiotherapeutic support. The study population will consist of low-risk parturients, with no prior cesarean indication, admitted to the sector. Those parturients who meet the inclusion criteria, after signing the Informed Consent Term, will be allocated to two groups: Group A (experimental) and Group B (control). Group A will be stimulated to keep the glottis minimally open during spontaneous pushing and to emit sounds when exhaling (vocalization), and Group B will undergo usual routine. Study outcomes will be evaluated by assistents immediately after delivery. After 24 hours of delivery, the conditions of the perineum will be assessed by inspection and palpation of the region,evaluating the presence of edema or other abnormality.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

SAMPLE SIZE As there are no studies to perform an adequate sample calculation, the present study will consist of 40 women, randomly randomized to use or not the vocalization technique, 20 in each group ( pilot exploratory study).

SAMPLING Sampling shall be obtained for convenience, consecutively.

Low-risk pregnant women admitted to the "Espaço Aconchego" sector who meet the eligibility criteria, will be questioned by the researcher about the interest in participating in the study in question. The objective of the vocalization technique will be explained to the pregnant woman, with the main aim being the prevention of perineal laceration and the probable prevention of postpartum complaints. In the case of parturients above 18 years, the Free and Informed Consent Form will be given and will be read and explained aloud, and only those who freely agree to participate, signing the term, will be included in the survey. In the case of under-age parturients, the legal guardians will sign the Informed Consent.

VARIABLE DEFINITIONS

Perineal laceration: categorical variable, involving two categories:

  • Present - when there is some degree of solution of continuity of the skin or mucosa in the posterior region of the perineum, which reaches or not the subcutaneous and the muscle.
  • Absent - defined as the posterior region of the intact perineum, without any solution of tissue continuity.

Duration of the active delivery period: numerical variable, determined in minutes (min), from total dilatation of the uterine cervix to the complete exit of the fetus associated with the spontaneous pull performed by the woman.

The degree of laceration will be classified according to the damaged tissues and defined according to the following criteria:

  • First degree laceration: involves the skin, the subcutaneous tissue and the vaginal mucosa or the combination of multiple superficial lacerations, reaching the tissues already mentioned;
  • Second degree laceration: involves the superficial muscles (bulbocavernosus and transverse); if it is deep, it also reaches the pubococcygeus muscle;
  • Third degree laceration: involves the set of superficial and deep muscles of the anal sphincter:
  • Fourth degree laceration: involves the set of muscles of the anal sphincter and the anal epithelium.

Location of vulvoperineal laceration

  • Anterior region: clitoris, small left lip, small right lip, left vestibular region and right vestibular region;
  • Posterior region: corresponding to the perineum itself (left side, right side and median region).

Size of laceration: extension in centimeters of perineal laceration; continuous numeric variable; Need for perineal suture: dichotomous categorical variable type (yes / no), expressed according to the need for perineal suture; Number of threads used for perineal suture: discrete numerical variable, corresponding to the number of threads partially or totally used for the suture of perineal lacerations; Use of oxytocin after randomization: dichotomous categorical variable (yes / no), defined by the placement or not of the hormone at the time of delivery, after randomization; Episiotomy: dichotomous categorical variable type (yes / no), defined as a surgical incision performed on the perineum at the time of vaginal delivery; Instrumental delivery: dichotomous categorical variable type (yes / no), after leasing of the forceps or vacuum-extractor, followed by elevation of the cephalic pole, if considered necessary; Perineal edema: dichotomous categorical variable type (yes / no), defined as fluid accumulation in the interstitium of perineal tissues by subjective evaluation of the examiner.66 Perineal Pain through the Visual Analogue Scale (EVA): continuous variable, describing the level of pain referred by the patient at each evaluation, ranging from zero to ten, with zero being the total absence of pain and ten the most extreme pain, unbearable, never felt in the course of life67 Maternal satisfaction: Categorical ordinal variable determining the level of maternal satisfaction after delivery. They will be considered satisfied, very satisfied, dissatisfied and not very satisfied.

Apgar scores of the newborn: continuous numerical variable, corresponding to the Apgar score recorded in the first and fifth minutes after birth, performed by the neonatologist, categorized as: 1 min ≥ 7, 1 min <7, 5 min ≥ 7, 5th min <7.

Need of resuscitation: categorical variable yes / no corresponding to the need for resuscitation of the baby after delivery from the PPV or larger interventions.

Neonatal ICU need: categorical variable type yes / no corresponding to the need for neonatal ICU, categorized as: yes or no.

Spontaneous Pushing: when performed without interference of the team assisting the parturient; Guided Guidance: when performed with interference from the team that assists the woman patient; Maternal Age: variable expressed in complete years, according to the patient's information, at the moment of data collection; Weight: Continuous numerical variable (which can later be categorized), expressed in kilos, indicating the weight of the patient at the moment of the study. Information collected by the patient's medical record; Height: Continuous numerical variable (can be later categorized), expressed in meters, indicating its height. Information collected from the medical records at the time of their selection to enter the study; BMI: continuous numerical variable, which represents the woman's body mass index. The formula for arriving at this value is weight / height²; Schooling: categorical variable informed by the patient and categorized as illiterate, high school, elementary school, higher education; Conjugal situation: categorical and police variables reported by the patient with or without a partner; Occupation: categorical variable informed by the patient; Kristeller's maneuver: dichotomous categorical variable, type yes / no, defining whether the parturient received some fundal pressure performed by the obstetric team. You will be informed by someone from the team who attended the delivery that saw the birth; Valsalva maneuver> six seconds: dichotomous categorical variable, yes / no type, indicating if the woman was instructed to perform forces contracting her perineal muscles and holding her breath at the moment of uterine contractions; Number of pregnancies: discrete variable. Expressed by the number of times the pregnant woman became pregnant, including the current gestation; Number of births: a discrete numerical variable, corresponding to the number of births (birth after 20 weeks or newborn weight greater than or equal to 500 grams), according to the patient's or family members' information; Gestational Age in Weeks: continuous variable, recorded as discrete, recorded in full weeks obtained preferably from the date of the last menstruation (LMP) or by ultrasonography; Newborn weight: numerical variable measured by the weight of the newborn in grams (g) immediately after birth; Cephalic perimeter of the Newborn: numerical variable measured in centimeters (cm) of the newborn's head circumference.

The statistical analysis will be carried out by the researchers, in addition to the statistician involved in the research, using the statistical programs Epi-Info 3.5.4 The statistical analysis will be performed with the groups identified as A or B, breaking the confidentiality only after obtaining the results and prepared tables. Thus, it will only be known which group was oriented on vocalization or not at the end of the analysis.

Categorical variables will be compared in contingency tables using the chi-square test of association and Fisher's exact test, when applicable. The risk ratio (RR) will be calculated as a relative risk measure for the primary and secondary outcomes, with a 95% confidence interval being determined. The numbers necessary to treat and obtain a benefit (NNT) and the number needed to treat and obtain a cure (NNH) and their respective 95% confidence intervals will still be calculated.

Regarding the continuous quantitative variables with dissimilar variances, if they present a normal distribution, the comparison between the groups will be performed with Student's t test for non-paired samples (parametric tests). If it is found that the distribution is not normal, the non-parametric Mann-Whitney test will be used. These tests will be used to identify the point differences between the two groups.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pernambuco
      • Recife, Pernambuco, Brazil, 50.070-550
        • Instituto Materno Infantil Prof. Fernando Figueira

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Low risk patients in active labor admitted to the IMIP; Gestational age between 37 and 42 weeks;
  • Cephalic fetus;
  • Cervical dilatation up to 8 cm at the time of inclusion in the study.

Exclusion Criteria:

  • Indication of cesarean section at the time of the approach;
  • Inability to understand and / or perform vocalization maneuvers.
  • Patients with Dysphonia
  • Deaf and mute patients
  • Use of Oxytocin prior to randomization

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: CONTROL
In this group parturients will be attended in standardized manner, which in our hospital means a humanized approach with choice of position in socond stage and without routine episiotomy.
Experimental: VOCALIZATION
In this group parturients will besides being be attended with our standar care, will receive training to vocalize during second stage.
The vocalization will be taught in voice form exhaled / sung in grave tones with the vowels, A, O and U.
Other Names:
  • vocalization technique
  • open glottis

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
PERINEAL LACERATION Primary outcome: 1. Perineal laceration - present or absent
Time Frame: 1 hour postpartum
Presence of perineal lacerations observed by the attending staff
1 hour postpartum

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
DURATION OF SECOND STAGE
Time Frame: 5 hours
time from complete dilation and delivery
5 hours
DURATION OF ACTIVE SECOND STAGE
Time Frame: 5 hours
time from spontaneous pushing to delivery
5 hours
oxytocin use
Time Frame: 5 hours
use of oxytocin after randomization
5 hours
episiotomy
Time Frame: 5 hours
performance of an episiotomy
5 hours
instrumental delivery
Time Frame: 5 hours
use of forceps por vacuum extractor for delivery
5 hours
laceration degree
Time Frame: 1 hour
degree of the laceration described by the assistant
1 hour
Suture need
Time Frame: 4 hours
need of laceration suturing (including spontaneous lacerations and episiotomies)
4 hours
Perineal edema
Time Frame: 24 hours
presence of perineal edema
24 hours
Maternal satisfaction with the management of the second period
Time Frame: 24 hours

Maternal satisfaction corresponding to the woman´s impressions and feelings with the management of her second period; evaluated with a scale were women will choose one of the following categories:

very unsatisfied =1 unsatisfied=2 satisfied=3 very satisfied =4

24 hours
Perineal pain
Time Frame: 24 hours

To assess the level of pain a combined scale of pain will be used, and the assessment of this scale meets the visual, categorical, numerical and face scale. The scale varies in discrete numbers from zero to ten, zero being the total absence of pain and ten the most extreme pain that can be felt.

(67. Chapman CR, Syrjala KL. Measurement of pain. In: Bonica JJ. Pain. 2nd ed. Pennsylvania: Lea & Febiger; 1990:580-94.)

24 hours
Apgar scores
Time Frame: 5 minutes
1st and 5th minute Apgar scores recorded in newborns chart
5 minutes
Neonatal ICU admission
Time Frame: 24 hour
ICU admission need recorded in newborns chart
24 hour
Need of ressuscitation
Time Frame: 24 hours
Ressuscitation need recorded in newborns chart
24 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2018

Primary Completion (Actual)

February 5, 2019

Study Completion (Actual)

February 5, 2019

Study Registration Dates

First Submitted

July 9, 2018

First Submitted That Met QC Criteria

July 26, 2018

First Posted (Actual)

July 30, 2018

Study Record Updates

Last Update Posted (Actual)

October 7, 2019

Last Update Submitted That Met QC Criteria

October 3, 2019

Last Verified

October 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • VOCAL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Perineal Tear

Clinical Trials on vocalization

3
Subscribe